Deutsche Bank
CLPT icon

Deutsche Bank’s ClearPoint Neuro CLPT Stock Holding History

Deutsche Bank’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.1M Buy
230,941
+2,808
+1% +$35.5K ﹤0.01% 1746
2025
Q4 		$3.12M Sell
228,133
-4,154
-2% -$77K ﹤0.01% 1537
2025
Q3 		$5.06M Buy
232,287
+206,901
+815% +$2.44M ﹤0.01% 1304
2025
Q2 		$303K Buy
25,386
+20,080
+378% +$253K ﹤0.01% 2728
2025
Q1 		$63.1K Buy
+5,306
New +$82.5K ﹤0.01% 3330
2024
Q2 		– Sell
-19,076
Closed -$130K – 3587
2024
Q1 		$130K Sell
19,076
-559
-3% -$3.91K ﹤0.01% 3046
2023
Q4 		$133K Sell
19,635
-6,278
-24% -$35.5K ﹤0.01% 3085
2023
Q3 		$130K Buy
+25,913
New +$154K ﹤0.01% 3040
2022
Q3 		– Sell
-4,951
Closed -$65K – 3986
2022
Q2 		$65K Sell
4,951
-6,336
-56% -$64.7K ﹤0.01% 3680
2022
Q1 		$118K Sell
11,287
-1,220
-10% -$11.1K ﹤0.01% 3524
2021
Q4 		$141K Buy
12,507
+602
+5% +$9.01K ﹤0.01% 3543
2021
Q3 		$211K Sell
11,905
-264
-2% -$4.95K ﹤0.01% 3543
2021
Q2 		$232K Buy
+12,169
New +$235K ﹤0.01% 3701

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Deutsche Bank's CLPT Position: Q1 2026 in Review

Deutsche Bank increased its ClearPoint Neuro (CLPT) stake by 1.2% in Q1 2026, buying an estimated $35.5K and bringing the position to 230,941 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1746.

Deutsche Bank first reported a position in CLPT in Q2 2021 and has held it in 13 quarters since. The position peaked at $5.06M in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Deutsche Bank held 230,941 shares of ClearPoint Neuro worth $2.1M as of Q1 2026.
  • Deutsche Bank bought 2,808 ClearPoint Neuro shares in Q1 2026, an estimated $35.5K.
  • ClearPoint Neuro made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1746 holding.
  • Deutsche Bank first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 13 quarters since.
  • Deutsche Bank's ClearPoint Neuro position peaked at $5.06M in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.